BioAge Labs

(NASDAQ) BIOA

Current Price$16.56

Market Cap$745.14M

Since IPO (2024)-8%

5 YearN/A

1 Year+306%

1 Month-5%

BioAge Labs Financials at a Glance

Market Cap

$745.14M

Revenue (TTM)

$8.99M

Net Income (TTM)

$80.61M

EPS (TTM)

$-2.24

P/E Ratio

-7.48

Dividend

$0.00

Beta (Volatility)

1.32 (Average)

Dividend

$0.00

Beta (Volatility)

1.32 (Average)

Price

$16.56

Volume

12,358

Open

$16.63

Price

$16.56

Volume

12,358

Open

$16.63

Previous Close

$16.56

Daily Range

$16.09 - $16.80

52-Week Range

$3.67 - $24.00

Dividend

$0.00

Beta (Volatility)

1.32 (Average)

Price

$16.56

Volume

12,358

Open

$16.63

Previous Close

$16.56

Daily Range

$16.09 - $16.80

52-Week Range

$3.67 - $24.00

BIOA News

Interested in Weight Loss Stocks Besides Novo Nordisk and Eli Lilly? You Might Want To Check Out This New IPO Stock

Adam SpataccoOct 12, 2024

scientist gestures to diagram on whiteboard

3 Reasons to Buy BioAge Labs Stock Hand Over Fist in October

Alex CarchidiOct 5, 2024

This IPO Biotech Stock Could Be the Next Eli Lilly

Alex CarchidiOct 3, 2024

BIOA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioAge Labs

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Kristen Fortney, PhD

Website

www.bioagelabs.com

Headquarters

Emeryville, CA 94804, US

BIOA Financials

Key Financial Metrics (TTM)

Gross Margin

99%

Operating Margin

-10%

Net Income Margin

-9%

Return on Equity

-27%

Return on Capital

-34%

Return on Assets

-27%

Earnings Yield

-13.37%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$745.14M

Shares Outstanding

44.38M

Volume

12.36K

Avg. Volume

531.24K

Financials (TTM)

Gross Profit

$8.99M

Operating Income

$92.78M

EBITDA

$92.78M

Operating Cash Flow

$81.63M

Capital Expenditure

$719.00K

Free Cash Flow

$82.35M

Cash & ST Invst.

$281.10M

Total Debt

$5.56M

BioAge Labs Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$3.08M

N/A

Gross Profit

$3.01M

N/A

Gross Margin

97.76%

N/A

Market Cap

$745.14M

N/A

Market Cap/Employee

$12.02M

N/A

Employees

N/A

Net Income

$25.94M

-22.8%

EBITDA

$28.42M

-36.9%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$275.54M

-20.3%

Accounts Receivable

$769.00K

N/A

Inventory

$0.00

N/A

Long Term Debt

$2.33M

-6.9%

Short Term Debt

$3.23M

-47.9%

Return on Assets

-27.33%

N/A

Return on Invested Capital

-33.77%

N/A

Free Cash Flow

$28.36M

-449.2%

Operating Cash Flow

$28.25M

-449.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ALLOAllogene Therapeutics, Inc.

ALLOAllogene Therapeutics, Inc.$2.26+5.12%

CGCCanopy Growth Corporation

CGCCanopy Growth Corporation$1.12-0.88%

AVIRAtea Pharmaceuticals, Inc.

AVIRAtea Pharmaceuticals, Inc.$5.70+2.15%

CABACabaletta Bio, Inc.

CABACabaletta Bio, Inc.$3.83+30.27%

EDITEditas Medicine, Inc.

EDITEditas Medicine, Inc.$3.00+3.45%

OMIOwens & Minor, Inc.

OMIOwens & Minor, Inc.$2.68+8.94%

ACBAurora Cannabis Inc.

ACBAurora Cannabis Inc.$3.42-1.72%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.14-0.01%

INTCIntel

INTCIntel$95.78-0.04%

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$7.84+2.39%

GBTGGlobal Business Travel Group

GBTGGlobal Business Travel Group$9.34+0.58%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.18+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.69-0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.91-0.01%

Questions About BIOA

What is the current price of BioAge Labs?

BioAge Labs is trading at $16.56 per share.

What is the 52-week range for BioAge Labs?

Over the past 52 weeks, BioAge Labs has traded between $3.67 and $24.00.

How much debt does BioAge Labs have?

As of the most recent reporting period, BioAge Labs reported total debt of $5.56M.

How much cash does BioAge Labs have on hand?

BioAge Labs reported $188.89M in cash and cash equivalents in its most recent financial results.

What is BioAge Labs’s dividend yield?

BioAge Labs does not currently have a dividend yield.

BioAge Labs

BioAge Labs Financials at a Glance

BIOA News

2 Reasons I Wouldn't Touch BioAge Labs Stock With a 10-Foot Pole

Citigroup Says This Obesity Drugmaker's Stock Is Now a Buy

Could This Anti-Obesity Drug Biotech Be Poised to Soar in 2026?

BioAge Labs Stock Just Soared. Does It Have More Fuel to Climb Higher?

BioAge Labs (BIOA) Q2 Revenue Hits $2.4M

Interested in Weight Loss Stocks Besides Novo Nordisk and Eli Lilly? You Might Want To Check Out This New IPO Stock

3 Reasons to Buy BioAge Labs Stock Hand Over Fist in October

This IPO Biotech Stock Could Be the Next Eli Lilly

BIOA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About BioAge Labs

BIOA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

BioAge Labs Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BIOA

What is the current price of BioAge Labs?

What is the 52-week range for BioAge Labs?

How much debt does BioAge Labs have?

How much cash does BioAge Labs have on hand?

What is BioAge Labs’s dividend yield?

Premium Investing Services